Jeffrey A. Miller
Practice Areas
Industries
Education
- The University of Texas School of Law, J.D., 1997, Order of the Coif
Texas Law Review, 1995-1997 - University of Virginia, B.A., 1994
Bar & Court Admissions
Jeff is of counsel in the Vorys Cincinnati office and a member of the litigation group. He specializes in complex litigation matters and False Claims Act (FCA) cases, and has additional experience with class action lawsuits, securities fraud cases, disputes over corporate control and internet defamation. He has successfully represented numerous clients in the federal and state courts of appeal.
His experience includes:
- Representing targets of Department of Justice investigations
- Convincing the Department of Justice not to intervene in FCA actions
- Defending contractors in FCA actions involving NASA, Air Force, Navy, Army, GSA and numerous other government agencies
- Assisting environmental contractors in FCA actions involving Department of Energy facilities
- Litigating FCA actions involving hospitals and physician groups
- Authoring numerous successful motions to dismiss and motions for summary judgment
- Negotiating settlement of FCA actions with the Department of Justice
- Helping obtain a directed verdict in a five-week qui tam FCA jury trial that ultimately resulted in a United States Supreme Court decision narrowing the scope of liability for defendants under the federal FCA
Jeff has presented at several conferences on topics including alternative dispute resolution, motion practice, construction law and technology issues.
Jeff received his J.D. from the University of Texas School of Law, where he was a member of the Texas Law Review and the Order of the Coif. He received his B.A. from the University of Virginia.
News
- 7/20/2018Jeff Miller, a senior attorney in the Vorys Cincinnati office, was quoted in a Bloomberg Government Federal Contracts Report story titled “High Hopes, 1 Result From Justice Department False Claims Memo.”
Events
- 10/16/2019The Vorys benefits team hosted the inaugural Vorys Benefits Conferences in Cincinnati on September 11, 2019 and in Columbus on October 16, 2019. These conferences were designed and developed specifically for in-house benefits professionals.
Insights
- 11/11/2019The United States District Court for the Eastern District of Pennsylvania recently endorsed a significant expansion to the Government’s ability to dismiss a qui tam relator’s False Claims Act (FCA) case.
- 4/18/2019Last month, the United States District Court for the Northern District of Illinois confronted a bank’s potential liability for false information obtained (and even allegedly encouraged) by bank employees in the processing of consumer loans.
- 4/8/2019In a recent decision, the United States District Court for the District of Minnesota held that the Department of Justice (DOJ) can still dismiss a qui tam filed under the False Claims Act even after it has declined to intervene in the case.
- 1/30/2018Although the government has always had the authority to move to dismiss relator cases, it almost never does, to the great frustration of numerous defendants that have had to incur the costs and inconvenience of meritless False Claims Act (FCA) claims.
- 1/12/2018In February 2017, a jury in the Middle District of Florida found for a relator in an upcoding case against a nursing home operator, resulting in a total judgment of approximately $350 million.
- 10/2/2017On September 29, 2017, the Fifth Circuit overturned a $664 million False Claims Act (FCA) judgment in U.S. ex rel. Harman v. Trinity Industries, Inc, Case No. 15-41172 (5th Cir). The court’s reasoning offers substantial ammunition to FCA defendants, and further demonstrates that courts really will enforce the strict materiality requirements outlined by the Supreme Court in Universal Health Servs., Inc. v. United States ex rel., Escobar, 136 S. Ct. 1989, 1995 (2016).
- 5/2/2017On May 1, 2017, the Third Circuit affirmed the dismissal of a False Claims Act (FCA) case in which the eelator had asserted that Genentech concealed information about side effects of its cancer drug, Avastin. U.S. ex rel. Petratos, v. Genentech Inc., et al., Case No. 15-3805 (3rd Cir. May 1, 2017).
- 12/19/2016On December 6, 2016, the Supreme Court of the United States handed down their second unanimous interpretation of the contours of the False Claims Act (FCA) in the last six months.
- 4/16/2014When the New York attorney general’s office cracked down on 19 companies in September for false reviews, it sent a loud and clear message to many businesses. For others, the combined $350,000 in fines may have simply been a wakeup call to get more creative with their deceptive online advertising practices.
- 3/4/2013U.S. District Court for the Northern District of Georgia Judge Thomas W. Thrash, Jr. recently granted a motion to dismiss qui tam claims from two relators who alleged that Lockheed Martin violated the False Claims Act by inflating the reported number of hours its employees worked on government contracts.
- 10/30/2009
- 1998